Skip to search formSkip to main contentSkip to account menu

imiglucerase

Known as: imiglucerase [Chemical/Ingredient] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Velaglucerase alfa is a glucocerebrosidase produced by gene activation technology in a human fibroblast cell line (HT‐1080), and… 
2011
2011
Highly Cited
2008
Highly Cited
2008
Progressive skeletal disease accounts for some of the most debilitating complications of type 1 Gaucher disease. In this 48‐month… 
Highly Cited
2008
Highly Cited
2008
To assess the extent to which patients with type 1 Gaucher disease (GD1) receiving individualized enzyme replacement therapy with… 
Highly Cited
2007
Highly Cited
2007
The effect of ERT with imiglucerase on BMD in type 1 GD was studied using BMD data from the International Collaborative Gaucher… 
Highly Cited
2007
Highly Cited
2007
Summary:  Purpose: Gaucher disease (GD) is an autosomal recessive lysosomal disorder caused by a deficiency of glucocerebrosidase… 
Highly Cited
2005
Highly Cited
2005
2004
2004
We have recently demonstrated that incubation of cultured rat hippocampal neurons with conduritol β-epoxide (CBE), an inhibitor… 
Review
2004
Review
2004
N-Butyldeoxynojirimycin (NB-DNJ, miglustat 'Zavesca') is an orallyactive iminosugar which inhibits the biosynthesis of…